Trademarkia Logo

Canada

C$
Trademark Search in Canada
REDx & Design

View On IC.GC.CA

REDx & Design
REGISTERED

on 10 Jun 2022

Last Applicant/ Owned by

Microbix Biosystems Inc.

265 Watline AvenueMississauga

ONTARIO

CA

L4Z1P3

Serial Number

1827114 filed on 13th Mar 2017

Registration Number

TMA1131387 registered on 10th Jun 2022

Registration expiry Date

10th Jun 2032

Correspondent Address

DLA PIPER (CANADA) LLP

BAY ADELAIDE - WEST TOWERSUITE 5100 - 333 BAY STREETTORONTO

ONTARIO

CA

M5H2R2

REDx & Design

Trademark usage description

quality assessment products namely proficiency testing samples, verification samples, validation samples, samples for operator training, and control s Read More

Vienna Information

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 19

Letters overlappingLettres se chevauchant

1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cells, images of bacteria or viruses, DNA helixesSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales, images de bactéries ou de virus, hélices d'ADN

27 . 3 . 1

Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an objectLettres ou chiffres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet

27 . 3 . 2

Letters or numerals representing a human being or a part of the human bodyLettres ou chiffres représentant un être humain ou une partie du corps humain

Classification Information

Class [001]
Quality assessment products namely proficiency testing samples, verification samples, validation samples, samples for operator training, and control samples for laboratory diagnostic use and testing of viruses, eukaryotes, prokaryotes, organisms, in whole and component parts, for scientific laboratory use; inactivated, native organisms namely pathogens, namely whole and fragmented eukaryotes, prokaryotes and viruses, independent and in host cells, and synthetic and recombinant DNA and RNA preparations, purified, and within host organisms, in various buffers, singly and in combination, which may be any one of liquid, frozen and lyophilized, for scientific laboratory use; Positive controls for use with molecular and diagnostic tests, namely tests detecting nucleic acids, proteins, carbohydrates, lipids, and biological molecules, to confirm proper test operation, and run in conjunction with patient samples to confirm, assess, test, and verify the operation of the test method, for scientific laboratory use; Proficiency test samples used to test the proficiency of operators, using infectious disease diagnostics test systems, to accurately and qualitatively determine the content of the sample for scientific laboratory use; Biological material for scientific purposes in the nature of serum and plasma from infected and disease state individuals used for verification and validation of human diagnostic assays for such infections and diseases; Biotechnology products for scientific purposes and not for medical or veterinary use, namely, reagents and solutions in the nature of viruses, bacteria, fungi, parasites, and derivatives thereof used to research, develop, manufacture, and validate infectious disease diagnostic tests; Laboratory assay kits for scientific laboratory use; Biological material, for scientific and research purposes, in the nature of serum or plasma from infected and disease state individuals used for verification and validation of human diagnostic assays for such infections and diseases; Biotechnology products for scientific and research use, namely, reagents and solutions in the nature of eukaryotes, prokaryotes, and viruses, and their component parts, and derivatives thereof for research, development, and validation of diagnostic tests, namely infectious disease diagnostic tests; diagnostic reagents containing lyophilized microorganisms, namely, reagents containing lyophilized eukaryotes, prokaryotes and viruses, and their component parts all for in-vitro use, and for use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for use in scientific research of infectious diseases; diagnostic reagents for medical research use; diagnostic preparations for medical research use; diagnostic preparations for use in scientific research of infectious diseases; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology.

Classification kind code

11

Class [005]
Quality assessment products namely proficiency testing samples, verification samples, validation samples, samples for operator training, and control samples for laboratory diagnostic use and testing of viruses, eukaryotes, prokaryotes, organisms, in whole and component parts, for medical laboratory use; inactivated, native organisms namely pathogens, namely whole and fragmented eukaryotes, prokaryotes and viruses, independent and in host cells, and synthetic and recombinant DNA and RNA preparations, purified, and within host organisms, in various buffers, singly and in combination, which may be any one of liquid, frozen and lyophilized, for medical laboratory use; Positive controls for use with molecular and diagnostic tests, namely tests detecting nucleic acids, proteins, carbohydrates, lipids, and biological molecules, to confirm proper test operation, and run in conjunction with patient samples to confirm, assess, test, and verify the operation of the test method for medical laboratory use; Proficiency test samples used to test the proficiency of operators, using infectious disease diagnostics test systems, to accurately and qualitatively determine the content of the sample for medical laboratory use; Biological material for diagnostic purposes in the nature of serum and plasma from infected and disease state individuals used for verification and validation of human diagnostic assays for such infections and diseases for medical laboratory use; diagnostic reagents for clinical laboratory use; diagnostic reagents for medical research; diagnostic reagents for medical diagnostic use; diagnostic reagents for medical laboratory use; diagnostic kits for in vitro use, namely for use in industry, science, and research; Diagnostic reagents, namely, biotechnology products for medical and veterinary use, namely, non-infectious organisms namely, pathogens, namely, eukaryotes, prokaryotes, and viruses, used for controls; diagnostic preparations for clinical laboratory use; diagnostic preparations for medical laboratory use; radio-isotope markers for diagnostic use.

Classification kind code

11

Class [009]
Laboratory instrument for the detection of pathogens and toxins in a biological sample for research use.

Classification kind code

11

Class [040]
Manufacturing of biotechnology products, namely pathogenic organisms for research, to the order and specification of others.

Classification kind code

11

Class [042]
Laboratory testing of materials.

Classification kind code

11

Class [044]
Medical testing services relating to the diagnosis and treatment of disease.

Classification kind code

11

Mark Details

Serial Number

1827114

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 15
on 28th Jun 2021		Correspondence Created
Submitted for opposition 15
on 15th Oct 2020		Correspondence Created
Submitted for opposition 12
on 29th Oct 2019		Extension of Time
Submitted for opposition 15
on 12th Apr 2019		Correspondence Created
Submitted for opposition 15
on 27th Sept 2018		Correspondence Created
Submitted for opposition 22
on 20th Feb 2018		Search Recorded
Submitted for opposition 20
on 20th Feb 2018		Examiner's First Report
Submitted for opposition 31
on 16th Mar 2017		Formalized
Submitted for opposition 1
on 14th Mar 2017		Created
Submitted for opposition 30
on 13th Mar 2017		Filed